SCOPE:Planning for Hybrid Querying over Clinical Trial Data

Fuente: arXiv
Salvato in:
Dettagli Bibliografici
Autori principali: Chowdhury, Suparno Roy, Choudhury, Manan Roy, Anvekar, Tejas, Khan, Muhammad Ali, Khakwani, Kaneez Zahra Rubab, Sonbol, Mohamad Bassam, Riaz, Irbaz Bin, Gupta, Vivek
Natura: Preprint
Pubblicazione: 2026
Soggetti:
Accesso online:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1866913079274504192
author Chowdhury, Suparno Roy
Choudhury, Manan Roy
Anvekar, Tejas
Khan, Muhammad Ali
Khakwani, Kaneez Zahra Rubab
Sonbol, Mohamad Bassam
Riaz, Irbaz Bin
Gupta, Vivek
author_facet Chowdhury, Suparno Roy
Choudhury, Manan Roy
Anvekar, Tejas
Khan, Muhammad Ali
Khakwani, Kaneez Zahra Rubab
Sonbol, Mohamad Bassam
Riaz, Irbaz Bin
Gupta, Vivek
contents We study clinical trial table reasoning, where answers are not directly stored in visible cells but must be reasoned from semantic understanding through normalization, classification, extraction, or lightweight domain reasoning. Motivated by the observation that current LLM approaches often suffer from "bad reasoning" under implicit planning assumptions, we focus on settings in which the model must recover implicit attributes such as therapy type, added agents, endpoint roles, or follow-up status from partially observed clinical-trial tables. We propose SCOPE (Structured Clinical hybrid Planning for Evidence retrieval in clinical trials), a multi-LLM planner-based framework that decomposes the task into row selection, structured planning, and execution. The planner makes the source field, reasoning rules, and output constraints explicit before answer generation, reducing ambiguity relative to direct prompting. We evaluate SCOPE on 1,500 hybrid reasoning questions over oncology clinical-trial tables against zero-shot, few-shot, chain-of-thought, TableGPT2, Blend-SQL, and EHRAgent. Results show that explicit multi-LLM planning improves accuracy for reasoning-based questions while offering a stronger accuracy-efficiency tradeoff than heavier agentic baselines. Our findings position clinical trial reasoning as a distinct table understanding problem and highlight hybrid planner-based decomposition as an effective solution
format Preprint
id arxiv_https___arxiv_org_abs_2604_25120
institution arXiv
publishDate 2026
record_format arxiv
spellingShingle SCOPE:Planning for Hybrid Querying over Clinical Trial Data
Chowdhury, Suparno Roy
Choudhury, Manan Roy
Anvekar, Tejas
Khan, Muhammad Ali
Khakwani, Kaneez Zahra Rubab
Sonbol, Mohamad Bassam
Riaz, Irbaz Bin
Gupta, Vivek
Computation and Language
We study clinical trial table reasoning, where answers are not directly stored in visible cells but must be reasoned from semantic understanding through normalization, classification, extraction, or lightweight domain reasoning. Motivated by the observation that current LLM approaches often suffer from "bad reasoning" under implicit planning assumptions, we focus on settings in which the model must recover implicit attributes such as therapy type, added agents, endpoint roles, or follow-up status from partially observed clinical-trial tables. We propose SCOPE (Structured Clinical hybrid Planning for Evidence retrieval in clinical trials), a multi-LLM planner-based framework that decomposes the task into row selection, structured planning, and execution. The planner makes the source field, reasoning rules, and output constraints explicit before answer generation, reducing ambiguity relative to direct prompting. We evaluate SCOPE on 1,500 hybrid reasoning questions over oncology clinical-trial tables against zero-shot, few-shot, chain-of-thought, TableGPT2, Blend-SQL, and EHRAgent. Results show that explicit multi-LLM planning improves accuracy for reasoning-based questions while offering a stronger accuracy-efficiency tradeoff than heavier agentic baselines. Our findings position clinical trial reasoning as a distinct table understanding problem and highlight hybrid planner-based decomposition as an effective solution
title SCOPE:Planning for Hybrid Querying over Clinical Trial Data
topic Computation and Language
url https://arxiv.org/abs/2604.25120